logo

For the Inventor, By the Inventor

Poynton, United Kingdom

Rodney B Hargreaves

USPTO Granted Patents = 24

Average Co-Inventor Count = 2.7

ph-index = 8

Forward Citations = 191(Granted Patents)


Company Filing History:

goldMedal24 out of 3,840 
 
Imperial Chemical Industries Limited
 patents

Years Active: 1983-1997

Loading Chart...
24 patents (USPTO):Explore Patents
1. 5654298 - Amine derivatives (1997-08-05),
2. 5574037 - Amino 1,3,5-triazine derivatives as agents for cardiovascular system (1996-11-12),
3. 5500428 - Furyl-substituted purines and adenosine antagonists (1996-03-19),
4. 5380714 - 2-furyl-triazalo [1,5-a]-[1,3,5]triazines and pyrazolo (1995-01-10),
5. 5332737 - Amino-1,3,5-triazines and their anhydrobase derivatives as agents for (1994-07-26),
6. 5328910 - Sino-atrial node modulating pyrrolopyrimidines (1994-07-12),
7. 5300509 - 2-furyl-oxazolo[5,4-d]-pyrimidines (1994-04-05),
8. 5252567 - Diazine derivatives (1993-10-12),
9. 5223505 - Pyrimidine derivatives (1993-06-29),
10. 4873254 - 1,4-Dihydropyridines substituted by 3-aryloxy-2-hydroxypropyl amino (1989-10-10),
11. 4788194 - Heterocyclic compounds (1988-11-29),
12. 4716164 - As-triazinones (1987-12-29),
13. 4694005 - 5-phenyl-3H,6H-1,3,4-oxadiazine-2-ones in treatment of heart failure and (1987-09-15),
14. 4683232 - Heterocyclic compounds having cardiotonic use (1987-07-28),
15. 4587246 - 1,3,4-thiadiazin-2-ones (1986-05-06),

Title: Innovations of Rodney B. Hargreaves in Pharmaceutical Chemistry

Introduction

Rodney B. Hargreaves, an inventive mind based in Poynton, GB, has made significant contributions to pharmaceutical chemistry with a portfolio of 24 patents. His inventive spirit has led to the development of novel compounds that impact various applications, particularly in the field of cardiovascular health.

Latest Patents

Among Hargreaves' latest patents is the invention of aminopyridinium compounds, which are characterized by complex formulas and various functional groups. These novel compounds offer a unique versatility in chemical applications. Additionally, he has developed amino 1,3,5-triazine derivatives designed as agents for the cardiovascular system. These compounds possess beneficial effects, particularly in modulating the function of the sino-atrial node, showcasing Hargreaves' commitment to advancing cardiovascular health through innovative chemistry.

Career Highlights

Hargreaves is currently associated with Imperial Chemical Industries Limited, a prominent player in the chemical industry. His career is marked by a focus on developing new chemical entities that hold therapeutic potential. With each patent, he not only demonstrates his inventiveness but also contributes to the wider body of pharmaceutical knowledge.

Collaborations

Throughout his career, Hargreaves has collaborated with esteemed colleagues, including Bernard J. McLoughlin and Stuart D. Mills. These partnerships have enriched his research endeavors and fostered innovation within the pharmaceutical community.

Conclusion

Rodney B. Hargreaves stands out as a key figure in the sphere of innovations related to cardiovascular pharmaceuticals. With his extensive patent portfolio and impactful collaborations, he continues to drive advancements in therapeutic solutions that benefit public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…